Mycetoma: Clinical Trials

7 trials for Mycetoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 1 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1
Phase 21Completed 1
Phase 41Completed 1

Follow Mycetoma: new trials by email Literature Review of Mycetoma trials Research Report on Mycetoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers
A mobile app with AI functionality for diagnosing skin-related NTDs - Skin and Connective Tissue Diseases, Neglected Tropical Diseases
Not applicableNot yet recruitingKenya Medical Research Institute24202026-05-012026-04-02
Mycetoma Retrospective Data Collection
A diagnosis of mycetoma in a medical, radiologic, or laboratory record. - Mycetoma
UnknownDrugs for Neglected Diseases16002024-06-202024-08-01
A Study on Rare Dermatological Infections Conducted at Three Major Reference Hospitals in Costa Rica.
Sporotrichosis, Chromomycosis
CompletedCaja Costarricense de Seguro Social952023-12-112024-07-29
Eumycetoma Long-term Post-Treatment Follow-Up Study
Clinical diagnosis of recurrence - Eumycetoma
TerminatedDrugs for Neglected Diseases512023-01-262024-07-23
Tissue Microenvironment Signatures of the Mycetoma Granuloma
Mycetoma
CompletedUniversity of Khartoum282019-03-072020-05-26
Proof-of-Concept Superiority Trial of Fosravuconazole Versus Itraconazole for Eumycetoma in Sudan
Fosravuconazole, Itraconazole - Mycetoma
Phase 2CompletedDrugs for Neglected Diseases1042017-05-092024-07-18
Efficacy Of Itraconazole In Chronic Cavitary Pulmonary Aspergillosis
Itraconazole, treatment in cavitary pulmonary aspergillosis - Chronic Cavitary Pulmonary Aspergillosis
Phase 4CompletedPost Graduate Institute of Medical Education and Research, Chandigarh312010-07-012012-02-22

Narrower conditions

Actinomycosis (1)  ·  Aspergillosis (1)  ·  Bacterial Infections and Mycoses (1)  ·  Blastomycosis (1)  ·  Buruli Ulcer (1)  ·  Chromoblastomycosis (1)  ·  Coccidioidomycosis (1)  ·  Elephantiasis (1)  ·  Elephantiasis, Filarial (1)  ·  Leishmaniasis, Cutaneous (1)  ·  Leprosy (1)  ·  Neglected Diseases (1)  ·  Nocardia Infections (1)  ·  Onchocerciasis (1)

Broader conditions

Actinomycetales Infections (7)  ·  Bacterial Infections (7)  ·  Dermatomycoses (7)  ·  Gram-Positive Bacterial Infections (7)  ·  Infections (7)  ·  Mycoses (7)  ·  Skin Diseases (7)  ·  Skin Diseases, Bacterial (7)  ·  Bacterial Infections and Mycoses (6)  ·  Nocardia Infections (6)  ·  Skin Diseases, Infectious (6)  ·  Skin and Connective Tissue Diseases (6)  ·  Disease Attributes (1)  ·  Ectoparasitic Infestations (1)  ·  Euglenozoa Infections (1)

Interventions

Itraconazole (2)  ·  Therapeutics (1)  ·  X-Rays (1)  ·  fosravuconazole L-lysine ethanolate (1)

Sponsors

Drugs for Neglected Diseases (3)  ·  Caja Costarricense de Seguro Social (1)  ·  Kenya Medical Research Institute (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  University of Khartoum (1)

Countries

Sudan (3)  ·  India (2)  ·  Senegal (2)  ·  Costa Rica (1)  ·  Democratic Republic of the Congo (1)  ·  Ethiopia (1)  ·  Kenya (1)  ·  Nigeria (1)

Top investigators

Ahmed Fahal, Prof (1)  ·  Borna A Nyaoke, M.D (1)  ·  Daniel E Barquero Orias, MD (1)  ·  Doudou Sow, PhD (1)  ·  Gustavo H Penaloza, PhD (1)  ·  Mohamed Osman, PhD (1)  ·  Shivaprakash M Rudramurthy, M.D (1)

Results publications

PMID 23496375, PMID 39098321, PMID 40433693, PMID 42607090